Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.8B | 9.4B | 9.1B | 9.1B |
Cost of revenue | 6.9B | 7.1B | 6.7B | 6.6B |
Gross profit | 1.8B | 2.3B | 2.4B | 2.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 632.3M | 665.8M | 644.7M | 576M |
Other operating expenses | 138.7M | 152.5M | 138.5M | 143.9M |
Operating income | 658.1M | 1.1B | 1.2B | 1.4B |
Non operating interest income | ||||
Income | 28.4M | 27.8M | 26.8M | 28.1M |
Expense | 127.3M | 127.2M | 140M | 141.3M |
Other income expense | -57.1M | 46.5M | 103.4M | 73.9M |
Pretax income | 502.1M | 1.0B | 1.2B | 1.4B |
Tax provision | 118M | 241.4M | 284.1M | 348.6M |
Net income | 384.1M | 780.9M | 909.6M | 1.1B |
Basic EPS | — | 0.7 | 0.8 | 0.9 |
Diluted EPS | — | 0.7 | 0.8 | 0.9 |
Basic average shares | — | 1.1B | 1.1B | 1.1B |
Diluted average shares | — | 1.1B | 1.1B | 1.1B |
EBITDA | 1.2B | 1.6B | 1.7B | 2.0B |
Net income from continuing op. | 384.2M | 780.9M | 909.6M | 1.1B |
Minority interests | 100K | -100K | -400K | -900K |
Preferred stock dividends | — | — | — | — |